参考文献/References:
[1] Rekha MR，Sharma CP.Oral delivery of therapeutic protein/peptide for diabetes-future perspectives [J].Int J Pharm，2013，
440（1）：48-62.
[2] Mukhopadhyay P，Chakraborty S，Bhattacharya S，et al.pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery [J].Int J Biol Macromol，2015，72： 640-648.
[3] Ensign LM，Cone R，Hanes J.Oral drug delivery with polymeric nanoparticles：the gastrointestinal mucus barriers[J].Adv Drug Deliv Rev，2012，64（6）：557-570.
[4] González-Mariscal L，Domínguez-Calderón A，Raya-Sandino A，et al.Tight junctions and the regulation of gene expression[J].Semin Cell Dev Biol，2014，36：213-223.
[5] Pawar VK，Meher JG，Singh Y，et al.Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics：strategies and industrial perspectives [J].J Control Release，2014，
196：168-183.
[6] Yun Y，Cho YW，Park K.Nanoparticles for oral delivery：targeted nanoparticles with peptidic ligands for oral protein delivery [J].Adv Drug Deliv Rev，2013，65（6）：822-832.
[7] Pridgen EM，Alexis F，Farokhzad OC.Polymeric nanoparticle technologies for oral drug delivery[J].Clin Gastroenterol Hepatol，2014，12（10）：1605-1610.
[8] Feng C，Sun G，Wang Z，et al.Transport mechanism of doxoru-bicin loaded chitosan based nanogels across intestinal epithelium[J]. Eur J Pharm Biopharm，2014，87（1）：197-207.
[9] Antunes F，Andrade F，Ferreira D，et al.Models to predict intestinal absorption of therapeutic peptides and proteins[J].Curr Drug Metab，2013，14（1）：4-20.
[10] Yeh TH，Hsu LW，Tseng MT，et al.Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening[J].Biomaterials，2011，32（26）：6164-6173.
[11] Sonaje K，Chuang EY，Lin KJ，et al.Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan：microscopic，ultrastructural，and computed-tomographic observations[J]. Mol Pharm，2012，9（5）：1271-1279.
[12] Hsu LW，Lee PL，Chen CT，et al.Elucidating the signaling mechanism of an epithelial tight-junction opening induced by chitosan[J]. Biomaterials，2012，33（26）：6254-6263.
[13] Moghassemi S，Parnian E，Hakamivala A，et al.Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes[J].Mater Sci Eng C Mater Biol Appl，2015，46：333-340.
[14] Mukhopadhyay P，Sarkar K，Chakraborty M，et al.Oral insulin delivery by self-assembled chitosan nanoparticles：in vitro and in vitro studies in diabetic animal model[J].Mater Sci Eng C Mater Biol Appl，2013， 33（1）：376-382.
[15] Makhlof A，Tozuka Y，Takeuchi H.Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery[J]. Eur J Pharm Sci，2011，42（5）：445-451.
[16] Moghassemi S，Parnian E，Hakamivala A，et al.Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes[J].Mater Sci Eng C Mater Biol Appl，2015，46：333-340.
[17] Mansourpour M，Mahjub R，Amini M，et al.Development of Acid-Resistant Alginate/Trimethyl Chitosan Nanoparticles Containing Cationic β-Cyclodextrin Polymers for Insulin Oral Delivery [J].AAPS Pharm Sci Tech，2015，[Epub ahead of print].
[18] Woitiski CB，Sarmento B，Carvalho RA，et al.Facilitated nanoscale delivery of insulin across intestinal membrane models[J].Int J Pharm，2011，412（1-2）：123-131.
[19] Wong TW，Sumiran N.Oral calcium pectinate-insulin nanoparticles：influences of alginate，sodium chloride and Tween 80 on their blood glucose lowering performance [J].J Pharm Pharmacol，2014，
66（5）：646-657.
[20] Kadir A，Mokhtar MT，Wong TW.Nanoparticulate assembly of mannuronic acid-and guluronic acid-rich alginate：oral insulin carrier and glucose binder[J].J Pharm Sci，2013，102（12）：4353-
4363.
[21] Han L，Zhao Y，Yin L，et al.Insulin-loaded pH-sensitive hyaluronic acid nanoparticles enhance transcellular delivery[J].AAPS Pharm Sci Tech，2012，13（3）：836-845.
[22] Ding J，He R，Zhou G，et al.Multilayered mucoadhesive hydrogel films based on thiolated hyaluronic acid and polyvinylalcohol for insulin delivery [J].Acta Biomater，2012，8（10）：3643-3651.
[23] Xiong XY，Li QH，Li YP，et al.Pluronic P85/poly（lactic acid） vesicles as novel carrier for oral insulin delivery[J].Colloids Surf B Biointerfaces，2013，111：282-288.
[24] Reix N，Parat A，Seyfritz E，et al.In vitro uptake evaluation in Caco-2 cells and in vitro results in diabetic rats of insulin-loaded PLGA nanoparticles[J].Int J Pharm，2012，437（1-2）：213-220.
[25] Yang J，Sun H，Song C.Preparation，characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly（lactic-co-glycolicacid） nanoparticles[J].Diabetes Obes Metab，2012，14（4）：
358-364.
[26] Zhang X，Sun M，Zheng A，et al.Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration[J].Eur J Pharm Sci，2012，45（5）：632-638.
[27] Gao X，Cao Y，Song X，et al.Biodegradable， pH-responsive carboxymethyl cellulose/poly（acrylic acid） hydrogels for oral insulin delivery[J].Macromol Biosci，2014，14（4）：565-575.
[28] Du X，Zhang J，Zhang Y，et al.Decanoic acid grafted oligochi-tosan nanoparticles as a carrier for insulin transport in the gastrointestinal tract[J].Carbohydr Polym，2014，111：433-441.
[29] Nielsen EJ，Yoshida S，Kamei N，et al.In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin[J].J Control Release，2014，
189：19-24.
[30] Zhang J，Zhu X，Jin Y，et al.Mechanism study of cellular uptake and tight junction opening mediated by goblet cell-specific trimethyl chitosan nanoparticles[J].Mol Pharm，2014，11（5）：1520-1532.
[31] Sonaje K，Lin KJ，Tseng MT，et al.Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endo-toxins [J].Biomaterials，2011，32（33）：8712-8721.
相似文献/References:
[1]李晏丽,宁光.microRNA与胰岛素抵抗[J].国际内分泌代谢杂志,2014,(03):188.[doi:10.3760/cma.j.issn.1673-4157.2014.03.012]
Li Yanli,Ning Guang..Relationship between microRNA and insulin resistance[J].International Journal of Endocrinology and Metabolism,2014,(04):188.[doi:10.3760/cma.j.issn.1673-4157.2014.03.012]